SEC fines Maximus $500K for not disclosing pay of exec’s siblings
By 
Jeff Dale2023-09-13T15:39:00
Government healthcare services corporation Maximus agreed to pay a $500,000 fine levied by the Securities and Exchange Commission (SEC) for allegedly failing to disclose an executive’s two siblings were also employed by the company and received annual compensation of more than $120,000.
Maximus will also cease and desist from further violations in reaching settlement, the SEC announced in an administrative proceeding Monday.
In October 2019, Maximus’s board of directors appointed a business segment leader and longtime employee as an executive officer, according to the SEC’s order.
Related articles
-
News BriefSkechers fined $1.25M over related person disclosure failures
Footwear company Skechers agreed to pay $1.25 million to settle charges by the Securities and Exchange Commission of failing to disclose payments to executives’ family members.
-
News Brief
Yieldstreet to pay $1.9M over securities offering disclosure lapses
Yieldstreet and its investment adviser affiliate agreed to pay more than $1.9 million as part of a settlement with the Securities and Exchange Commission addressing allegations the firm did not disclose heightened risks regarding a $14.5 million asset-backed securities offering.
-
News Brief
Mortgage industry adviser fined $100K over long-running compliance lapses
Mortgage Industry Advisory Corp. agreed to pay $100,000 to settle allegations levied by the Securities and Exchange Commission it failed to adopt and implement written compliance policies and procedures, conduct annual reviews, and establish and enforce a code of ethics.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”